Drugging the epigenome in the age of precision medicine

202396 citationsReviewgold Open Access

Authors

John Mendlein · Flagship Pioneering (United States)

Thomas McCauley · Omega Consult (Slovenia)

Abstract

Novel therapeutic modalities leveraging epigenetics and epigenomics with increased precision are well positioned to advance the field and treat patients across disease areas in the coming years.

Topics & Keywords

Epigenetics and DNA Methylation Histone Deacetylase Inhibitors Research Protein Degradation and Inhibitors

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Clinical Epigenetics

Volume 15, Issue 1, pp. 6-6

DOI: 10.1186/s13148-022-01419-z

Field-Weighted Citation Impact: 15.00